We're thrilled to share that Antibodies Inc has welcomed Biosensis to our family of companies!
This exciting partnership strengthens our commitment to delivering exceptional products and services and enhances our ability to serve you better. By uniting complementary strengths in neuroscience biomarker ELISAs, validated research antibodies, chicken IgY technologies, phosphospecific expertise, and advanced cell viability and immunoassay reagents, we're expanding what's possible for researchers.
Biosensis specializes in ELISA kits, antibodies, proteins, and staining reagents for neuroscience research, with a focus on neurodegenerative diseases, neurodevelopment, and neuro-metabolism. Key research areas include Alzheimer's, Parkinson's, ALS, Autophagy, metabolic and stress disorders, obesity, and neuroinflammation.
Highlighted products include Biosensis' unique Rapid ELISA kits for BDNF, NGF isoforms, and NGFR/p75ECD, as well as their Oligomeric Amyloid-beta ELISA, Amylo-Glo amyloid plaque staining reagents, and Fluoro-Jade B and C neuronal degeneration tracers.
What This Means for You:
- Expanded Product Offerings: Soon you'll find Biosensis' full range of products available on our website, making it easier to explore and access our combined solutions
- Enhanced Capabilities: Benefit from ELISA Kits, New antibodies, and Dyes and Staining Reagents designed to address your evolving needs.
- Future Innovations: Look forward to exciting updates as we integrate Biosensis' expertise to bring you even more research opportunities.
Together we'll continue to innovate and deliver the quality you expect. We're excited about the possibilities this brings and remain dedicated to your success. On behalf of all of us, thank you for trusting us with your research. We're committed to making this transition additive for your sciences: delivering faster answers, stronger data, and more support when experiments get challenging.
If you have any questions, please feel free to contact us.

